-+ 0.00%
-+ 0.00%
-+ 0.00%
Novartis Updates Medium-term Guidance
Share
Listen to the news
01:24 AM EST, 11/19/2026 (MT Newswires) -- Novartis (NOVN.SW) updated its guidance for the medium term covering 2026 to 2031, according to a Thursday release. The Swiss drugmaker expects net sales to grow at a compound annual growth rate of 5% in constant currencies during the period.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending